Chewable DGL

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

Glycyrrhiza glabra, Quantity: 400 mg (Equivalent: Glycyrrhiza glabra, Qty 4 g)

Available from:

Factors Group Australia Pty Ltd

Pharmaceutical form:

Tablet, chewable

Composition:

Excipient Ingredients: silicon dioxide; magnesium stearate; stearic acid; Aniseed Powder; microcrystalline cellulose; xylitol; Stevia rebaudiana

Administration route:

Oral

Therapeutic indications:

Anti-inflammatory/relieve inflammation ; Demulcent/soothe irritated tissues ; Decrease/reduce/relieve abdominal pain/discomfort ; Decrease/reduce/relieve symptoms of heartburn ; Helps decrease/reduce/relieve mild gastrointestinal tract inflammation ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve throat mucous membrane irritation/inflammation

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2019-07-31

View documents history